12/20/2023GSK Enters Exclusive License Agreement with Hansoh for ADC HS-20093

12/19/2023GSK Is Hunting for Deals in China: FT

12/18/2023Pfizer/Seagen Pick Up HBM/NonaBio's ADC HBM9033 in $1B License Deal

12/18/2023CBMG Holdings Announces Name Change to AbelZeta Pharma, Inc. (Free)

12/18/2023AbelZeta Announces Amendment to Worldwide Collaboration and License Ag...

12/15/2023Review of Top 15 Chinese Pharma In-Licensing Deals in 2023

12/13/2023U.S. FDA Clinical Hold Puts CARsgen's Global Expansion Plans in Jeopar...

12/12/2023Pharma MNCs Forge More Local Alliances for Growth in China's Dynamic H...

12/12/2023BMS and SystImmune Announce a Global Strategic Deal for ADC BL-B01D1

12/10/2023LianBio Rejects Unsolicited Proposal from Concentra Biosciences

12/10/2023AstraZeneca and AbelZeta to Co-Develop a Novel GPC3 Armored CAR-T Ther...

12/10/2023WuXi Biologics Successfully Implemented a Fully Integrated Continuous ... (Free)

12/7/2023Innovent Biologics and Synaffix Expand ADC Collaboration

12/5/2023Richter and Mithra Sign Deal to Commercialize Estetrol Containing Prod...

12/5/2023Merck Group and Abbisko Strike Licensing Deal for Pimicotinib for Chin...

12/4/2023Aspen Pharma Makes Further Inroads into China by Taking Over Sandoz Ch...

12/4/2023Tang Capital's Concentra Bio Makes Unsolicited Bid for LianBio

12/4/2023Novartis to Invest CNY 600M for Second Production Site in Zhejiang

11/30/2023Financial-related Company News Digest (November 2023)

11/28/2023Takeda China Expands Collaborations for Digital Healthcare Innovation ...

11/28/2023Evommune and Accutar Biotech Announce AI Drug Discovery Collaboration

11/27/2023Moderna Begins Work on Its mRNA China Plant

11/27/2023Indian Pharma to Benefit amid Big Pharma's China De-Risking

11/27/2023Coherus Sets Price of China-Made PD-1 Inhibitor Loqtorzi at a 20% Disc...

11/27/2023AstraZeneca to open Hong Kong R&D centre by late 2024 at earliest with...

11/26/2023Dizal Strikes Derma Drug JV Deal with Wuxi High-tech Zone

11/26/2023Zhifei to Acquire Chenan to Expand into Metabolic Disease Drugs

11/23/2023Myricx Concludes Global Licence Deal for WuXi Bio's Antibody

11/22/2023Acrometa to Strengthen Biopharma Presence in China by Developing Co-Wo... (Free)

11/21/2023Tencent Sets Sights on China's Multibillion-Dollar Healthcare Sector w...

Page:5/13 Total number of articles:371: [First][<<] [3] [4] [5] [6] [7] [>>] [End]